Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen E Wolverton

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Archives of Dermatology|June 17, 2009
Optimizing clinical use of azathioprine with newer pharmacogenetic dataStephen E Wolverton
Dermatologic Therapy|October 23, 2009
Can short courses of systemic corticosteroids truly cause osteonecrosis?Stephen E Wolverton
Dermatologic Clinics|July 2, 2016
Practice Gaps: Drug ReactionsStephen E Wolverton
Dermatologic Therapy|October 23, 2009
Controversies in dermatologic drug therapyStephen E Wolverton
Dermatologic Clinics|April 14, 2007
Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugsStephen E Wolverton, Kathleen Remlinger
Archives of Dermatology|January 20, 2010
Recent trends in systemic psoriasis treatment costsVivianne Beyer, Stephen E Wolverton
American Journal of Clinical Dermatology|April 6, 2013
Important controversies associated with isotretinoin therapy for acneStephen E Wolverton, Julie C Harper
JAMA Dermatology|February 22, 2013
Top-accessed article: topical rapamycinAnita N Haggstrom, Stephen E Wolverton
Journal of Drugs in Dermatology : JDD|October 19, 2007
The efficacy and safety of rituximab in refractory pemphigus: a review of case reportsKattie J Allen, Stephen E Wolverton
Journal of the American Academy of Dermatology|February 18, 2014
Drug hypersensitivity syndrome in a patient receiving vismodegibThomas Lam, Stephen E Wolverton, Carrie L Davis
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Archives of Dermatology|June 17, 2009
Optimizing clinical use of azathioprine with newer pharmacogenetic dataStephen E Wolverton
Dermatologic Therapy|October 23, 2009
Can short courses of systemic corticosteroids truly cause osteonecrosis?Stephen E Wolverton
Dermatologic Clinics|July 2, 2016
Practice Gaps: Drug ReactionsStephen E Wolverton
Dermatologic Therapy|October 23, 2009
Controversies in dermatologic drug therapyStephen E Wolverton
Dermatologic Clinics|April 14, 2007
Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugsStephen E Wolverton, Kathleen Remlinger
Archives of Dermatology|January 20, 2010
Recent trends in systemic psoriasis treatment costsVivianne Beyer, Stephen E Wolverton
American Journal of Clinical Dermatology|April 6, 2013
Important controversies associated with isotretinoin therapy for acneStephen E Wolverton, Julie C Harper
JAMA Dermatology|February 22, 2013
Top-accessed article: topical rapamycinAnita N Haggstrom, Stephen E Wolverton
Journal of Drugs in Dermatology : JDD|October 19, 2007
The efficacy and safety of rituximab in refractory pemphigus: a review of case reportsKattie J Allen, Stephen E Wolverton
Journal of the American Academy of Dermatology|February 18, 2014
Drug hypersensitivity syndrome in a patient receiving vismodegibThomas Lam, Stephen E Wolverton, Carrie L Davis
Pageof 2